Marshall Wace’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,969
| Closed | -$155K | – | 2526 |
|
|
2022
Q3 | $155K | Sell |
15,969
-106,259
| -87% | -$1.03M | ﹤0.01% | 2379 |
|
|
2022
Q2 | $1.77M | Buy |
+122,228
| New | +$1.77M | ﹤0.01% | 1641 |
|
|
2021
Q4 | – | Sell |
-73,321
| Closed | -$3.67M | – | 3325 |
|
|
2021
Q3 | $3.67M | Buy |
+73,321
| New | +$3.67M | 0.02% | 959 |
|
|
2021
Q2 | – | Sell |
-544,171
| Closed | -$25.5M | – | 2261 |
|
|
2021
Q1 | $25.5M | Sell |
544,171
-386,015
| -41% | -$18.1M | 0.12% | 158 |
|
|
2020
Q4 | $40.5M | Buy |
930,186
+70,456
| +8% | +$3.07M | 0.22% | 80 |
|
|
2020
Q3 | $31.5M | Sell |
859,730
-54,023
| -6% | -$1.98M | 0.2% | 98 |
|
|
2020
Q2 | $26.7M | Sell |
913,753
-106,605
| -10% | -$3.11M | 0.19% | 106 |
|
|
2020
Q1 | $26.7M | Buy |
+1,020,358
| New | +$26.7M | 0.27% | 79 |
|